Salubrinal protects cardiomyocytes against apoptosis in a rat myocardial infarction model via suppressing the dephosphorylation of eukaryotic translation initiation factor 2α

Ruijun Li, Kunlun He, Xin Li, Lili Wang, Chunlei Liu, Yunyun HeMolecular 2015 · DOI

Abstract

This study investigates the role of eukaryotic translation initiation factor 2α (eIF2α) in cardiomyocyte apoptosis and evaluates the cardioprotective potential of salubrinal in a rat myocardial infarction (MI) model. Following ligation of the left anterior descending coronary artery, researchers analyzed proteins involved in the endoplasmic reticulum stress (ERS)-induced apoptotic pathway. Results indicated that MI increases levels of GRP78, caspase-12, CHOP, and p-eIF2α. Treatment with salubrinal was found to decrease cardiomyocyte apoptosis and infarct size by promoting eIF2α phosphorylation and suppressing pro-apoptotic markers. These findings suggest that salubrinal offers protection against ERS-induced cell death by modulating the eIF2α pathway.

Introduction: Addressing Myocardial Apoptosis

When a heart attack (myocardial infarction, or MI) occurs, the sudden loss of blood flow causes massive cell death. While immediate necrosis occurs due to oxygen deprivation, a substantial portion of heart tissue loss is attributed to apoptosis—a programmed form of cell suicide—occurring in the hours and days following the event.

A major driver of this apoptosis is Endoplasmic Reticulum Stress (ERS). The ER is the cell's protein-folding factory; when it is overwhelmed by hypoxia or nutrient deprivation, it triggers the Unfolded Protein Response (UPR). Initially, the UPR is protective, attempting to restore balance. However, if the stress is too severe or prolonged, the UPR activates "death markers" like CHOP and caspase-12, leading to irreversible cell loss. This study investigated whether pharmacologically maintaining the protective phase of the UPR could prevent this self-destruct sequence.

Methodology

The researchers used a standard rat model of MI, where the left anterior descending (LAD) coronary artery was ligated. They compared three main groups: a "sham" surgery group (control), an untreated MI group, and an MI group treated with Salubrinal (1 mg/kg).

Key techniques included:

  • Molecular Analysis: RT-qPCR and Western Blotting were used to measure the mRNA and protein levels of stress markers (GRP78) and apoptotic markers (CHOP, caspase-12).
  • Phosphorylation Tracking: They specifically measured the levels of phosphorylated eIF2α (p-eIF2α), which is the target of Salubrinal.
  • Histology and Staining: TTC staining visualized the physical size of the infarct, and TUNEL staining quantified the rate of individual cell apoptosis.
  • Enzyme Assays: Serum levels of LDH and CK (damage markers) and SOD (an antioxidant enzyme) were measured.

Key Insights: The Role of eIF2α and Temporal Stress

The protein eIF2α is a critical gatekeeper. When it is phosphorylated, it slows down general protein synthesis, which lightens the load on a stressed ER. Salubrinal acts as a specific inhibitor of the enzyme that removes that phosphate. By keeping eIF2α in its phosphorylated state, Salubrinal keeps the "slow down" signal active, giving the cell more time to recover.

The study mapped the timeline of ERS post-MI, finding that protective markers like GRP78 and p-eIF2α peak early (around 6 hours), while pro-apoptotic markers continue to rise toward the 24-hour mark. This confirms a critical therapeutic window where intervention can prevent the transition from "stressed" to "dead."

Figure 6: Temporal expression of GRP78 mRNA (A), GRP78 protein (B), and p-eIF2α/eIF2α ratio (C) in rat heart tissue following myocardial infarction.

Key Results

  • Reduced Infarct Size: TTC staining showed that Salubrinal significantly decreased the physical area of dead heart tissue compared to the untreated MI group.
  • Lower Apoptotic Index: TUNEL staining revealed a sharp decrease in the number of apoptotic cardiomyocytes in the Salubrinal-treated rats.
  • Molecular Suppression: Salubrinal treatment successfully increased levels of p-eIF2α and, consequently, led to a significant reduction in the expression of the "death signals" CHOP and caspase-12.
  • Improved Biomarkers: Treatment lowered the levels of LDH and CK—enzymes that leak into the blood when heart cells are damaged—indicating better overall preservation of the heart muscle.

Limitations and Future Work

While promising in rats, clinical translation remains complex due to the timing of drug administration in human emergency settings. Future research is needed to determine optimal dosage and potential side effects of long-term eIF2α inhibition. Additionally, while this study focused on the PERK/eIF2α pathway, the roles of other ERS branches (IRE1 and ATF6) in Salubrinal's protective effect require further clarification to ensure long-term prevention of heart failure.

Summary updated

Abstract

The aim of the present study was to examine the role of eIF2α in cardiomyocyte apoptosis and evaluate the cardioprotective role of salubrinal in a rat myocardial infarction (MI) model. Rat left anterior descending coronary arteries were ligated and the classical proteins involved in the endoplasmic reticulum stress (ERS)-induced apoptotic pathway were analyzed using quantitative polymerase chain reaction and western blot analysis. Salubrinal was administered to the rats and cardiomyocyte apoptosis and infarct size were evaluated by a specific staining method. Compared with the sham surgery group, the rate of cardiomyocyte apoptosis in the MI group was increased with the development of the disease. It was also demonstrated that the mRNA and protein levels of GRP78, caspase-12, CHOP and the protein expression of p-eIF2α were increased in the MI group. Furthermore, the results showed that treatment with salubrinal can decrease cardiomyocyte apoptosis and infarct size by increasing eIF2α phosphorylation and decreasing the expression of caspase-12 and CHOP. The present study suggests that salubrinal protects against ER stress-induced rat cadiomyocyte apoptosis via suppressing the dephosphorylation of eIF2α in the ERS-associated pathway.
BibTeX
@inproceedings{li2015salubrinal,
  author = {Ruijun Li and Kunlun He and Xin Li and Lili Wang and Chunlei Liu and Yunyun He},
  title = {{Salubrinal protects cardiomyocytes against apoptosis in a rat myocardial infarction model via suppressing the dephosphorylation of eukaryotic translation initiation factor 2α}},
  booktitle = {Molecular},
  year = {2015},
  doi = {10.3892/mmr.2015.3508},
}
Figure